BeStock  
Stocks › Medical Devices › PACB

Pacific Biosciences of California PACB

US equityMarket cap rank #3575Medical Devices
$1.63 −$0.13 (-7.39%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $1.63 +0.28%
Open$1.69
Prev close$1.76
Day range$1.61 – $1.73
Volume13.69M
Market cap$510.07M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$40.56M+5.5% YoY
Operating profit-$37.00M+4.8% YoY
Net profit-$37.85M+0.4% YoY
Diluted EPS-$0.12+7.7% YoY
Free cash flow-$38.59M-107.3% YoY
Operating cash flow-$37.61M

Revenue, last 8 quarters

$39.2MDec '24$37.2MMar '25$39.8MJun '25$38.4MSep '25$44.6MDec '25$37.2MMar '26$39.0MJun '26$40.6MSep '26

Net profit, last 8 quarters

$2.4MDec '24$-426.1MMar '25$-41.9MJun '25$-38.0MSep '25$-40.4MDec '25$-8.3MMar '26$-44.7MJun '26$-37.8MSep '26

Diluted EPS by quarter

-0.49Dec '24-1.44Mar '25-0.14Jun '25-0.13Sep '25-0.13Dec '25-0.03Mar '26-0.14Jun '26-0.12Sep '26

Free cash flow by quarter

$-32.3MDec '24$-50.4MMar '25$-29.9MJun '25$-18.6MSep '25$-19.9MDec '25$-52.7MMar '26$-39.2MJun '26$-38.6MSep '26

Annual revenue

$78.9MFY20$130.5MFY21$128.3MFY22$200.5MFY23$154.0MFY24$160.0MFY25

Profitability & balance sheet

Gross margin34.4%
Operating margin-100.1%
Net margin-81.3%
Return on assets-17.2%
Current ratio4.62
Liabilities / assets108.5%
Cash & investments$199.42M
Total debt$703.30M
Net cash (debt)-$503.88M

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Consumable revenue$20.82M 51.3%
  • Instrument revenue$13.18M 32.5%
  • Service and other revenue$6.56M 16.2%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $40.56M $39.01M $37.18M $160.01M $44.65M
Total Operating Revenue $40.56M $39.01M $37.18M $160.01M $44.65M
Cost of Revenue $27.09M $26.37M $24.34M $114.23M $28.08M
Gross Profit $13.47M $12.64M $12.84M $45.78M $16.57M
Operating Expense $50.47M $57.25M $66.99M $603.34M $57.76M
Selling and Admin Expenses $29.42M $33.39M $31.15M $141.49M $34.05M
Research & Development $20.22M $23.02M $19.61M $97.31M $22.88M
Depreciation & Amortization & Depletion $833,000.00 $833,000.00 $833,000.00 $364.54M $833,000.00
-Depreciation & Amortization $833,000.00 $833,000.00 $833,000.00 $364.54M $833,000.00
Operating Profit -$37.00M -$44.61M -$54.15M -$557.56M -$41.20M
Net Non-Operating Interest Income (Expense) -$2.06M -$2.11M -$1.74M -$6.95M -$1.74M
Non-Operating Interest Expense $2.06M $2.11M $1.74M $6.95M $1.74M
Other Income (Expense) $1.48M $2.04M $47.80M $18.46M $2.77M
Special Income (Charges) $0.00 $0.00 $45.80M $3.70M $0.00
-Less:Restructuring and Mergern & Acquisition $0.00 $0.00 $0.00 -$18.70M $0.00
-Less:Write Off $0.00 $0.00 $0.00 $15.00M $0.00
-Gain on Sale of Property/Plant/Equipment $0.00 $0.00 $45.80M – –
Other Non-Operating Income (Expenses) $1.48M $2.04M $2.01M $14.76M $2.77M
Pretax Profit -$37.58M -$44.68M -$8.09M -$546.06M -$40.17M
Tax $269,000.00 $58,000.00 $184,000.00 $318,000.00 $202,000.00
Net Profit -$37.85M -$44.74M -$8.28M -$546.38M -$40.37M
Profit from Continuing Operations -$37.85M -$44.74M -$8.28M -$546.38M -$40.37M
Net Income to Parent Company -$37.85M -$44.74M -$8.28M -$546.38M -$40.37M
Net Income to Common Stockholders -$37.85M -$44.74M -$8.28M -$546.38M -$40.37M
Basic EPS -$0.12 -$0.14 -$0.03 -$1.82 -$0.13
Diluted EPS -$0.12 -$0.14 -$0.03 -$1.82 -$0.13
Other Operating Expenses – – $15.40M – –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $721.10M $751.85M $782.37M $784.08M $784.08M
Total Current Assets $307.85M $338.64M $369.52M $375.05M $375.05M
Cash and Cash Equivalents & Short-Term Investments $199.42M $236.87M $275.96M $279.51M $279.51M
-Cash and Cash Equivalents $55.91M $61.00M $56.27M $63.71M $63.71M
-Short Term Investments $143.51M $175.87M $219.69M $215.80M $215.80M
Receivables $38.32M $31.10M $29.35M $35.45M $35.45M
-Accounts Receivable $38.32M $31.10M $29.35M $35.45M $35.45M
Inventory $60.28M $61.08M $51.02M $49.29M $49.29M
Restricted Cash $33,000.00 $33,000.00 $19,000.00 $20,000.00 $20,000.00
Other Current Assets $9.80M $9.55M $13.16M $10.79M $10.79M
Total Non-Current Assets $413.24M $413.21M $412.85M $409.03M $409.03M
Net PPE $68.69M $67.30M $65.22M $65.84M $65.84M
-Gross PPE $68.69M $67.30M $65.22M $158.31M $158.31M
Goodwill and Other Intangible Assets $329.93M $330.85M $331.87M $332.89M $332.89M
-Goodwill $317.76M $317.76M $317.76M $317.76M $317.76M
-Other Intangible Assets $12.16M $13.08M $14.10M $15.12M $15.12M
Other Non-Current Assets $14.63M $15.06M $15.76M $10.31M $10.31M
Total Liabilities $782.48M $785.06M $780.00M $778.73M $778.73M
Total Current Liabilities $66.59M $68.81M $65.36M $72.83M $72.83M
Payables $10.92M $19.22M $13.61M $20.77M $20.77M
-Accounts Payable $10.92M $19.22M $13.61M $20.77M $20.77M
Current Accrued Expenses $33.81M $30.32M $33.90M $33.65M $33.65M
Short-Term Debt and Capital Lease Obligation $2.07M $1.37M $277,000.00 $448,000.00 $448,000.00
-Current Capital Lease Obligation $2.07M $1.37M $277,000.00 $448,000.00 $448,000.00
Current Deferred Liabilities $17.34M $16.10M $16.33M $15.94M $15.94M
Other Current Liabilities $2.46M $1.79M $1.24M $654,000.00 $654,000.00
Total Non-Current Liabilities $715.88M $716.26M $714.64M $705.90M $705.90M
Long Term Debt and Capital Lease Obligation $703.30M $704.76M $703.11M $701.97M $701.97M
-Long Term Debt $643.06M $644.33M $644.11M $645.38M $645.38M
-Long Term Capital Lease Obligation $60.24M $60.42M $59.00M $56.59M $56.59M
Non-Current Deferred Liabilities $4.23M $3.34M $3.55M $3.93M $3.93M
Other Non-Current Liabilities $8.35M $8.16M $7.98M – –
Total Equity -$61.38M -$33.21M $2.37M $5.35M $5.35M
Stockholders' Equity -$61.38M -$33.21M $2.37M $5.35M $5.35M
Capital Stock $312,000.00 $311,000.00 $311,000.00 $302,000.00 $302,000.00
-Common Stock $312,000.00 $311,000.00 $311,000.00 $302,000.00 $302,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $2.73B $2.72B $2.71B $2.70B $2.70B
Retained Earnings -$2.79B -$2.75B -$2.70B -$2.70B -$2.70B
Gains/Losses Not Affecting Retained Earnings -$819,000.00 -$503,000.00 -$147,000.00 $457,000.00 $457,000.00
-Accumulated Depreciation – – – -$92.47M -$92.47M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$37.61M -$35.58M -$44.69M -$111.21M -$19.07M
Net cash flow from continuing operations -$37.61M -$35.58M -$44.69M -$111.21M -$19.07M
Net Income from Continuing Operations -$37.85M -$44.74M -$8.28M -$546.38M -$40.37M
Gain/Loss from Continuing Operations $0.00 $0.00 -$48.10M – –
Depreciation & Depletion & Amortization $4.77M $4.52M $4.07M $386.41M $4.65M
Deferred Tax $0.00 $0.00 $0.00 -$546,000.00 $0.00
Other Non-Cash Items $356,000.00 $225,000.00 $225,000.00 -$17.01M $232,000.00
Change in Working Capital -$11.95M -$5.99M $3.17M $4.44M -$2.28M
-Change in Receivables -$7.22M -$1.75M $6.10M -$7.92M -$4.83M
-Change in Inventory -$1.39M -$11.26M -$3.21M -$1.42M -$6.26M
-Change in Prepaid Assets -$326,000.00 $1.86M -$2.29M $8.51M $717,000.00
-Change in Payables and Accrued Expense -$6.31M $3.40M -$4.01M $5.64M $6.28M
-Change in Other Current Liabilities $1.17M $2.20M $6.56M -$470,000.00 $2.41M
-Change In Other Working Capital $2.13M -$442,000.00 $19,000.00 $101,000.00 -$584,000.00
Net cash flow from investing $31.11M $40.07M $35.86M $115.45M $26.03M
Net Cash Flow from Continuing Investing Activities $31.11M $40.07M $35.86M $115.45M $26.03M
Net PPE Purchase and Sale -$988,000.00 -$1.56M -$3.04M -$2.71M -$861,000.00
Net Intangibles Purchase and Sale $0.00 -$2.06M -$5.00M -$5.00M $0.00
Net Investment Purchase and Sale $32.10M $43.68M -$4.20M $123.16M $26.89M
Net Other Investing Changes $0.00 $0.00 $48.10M – –
Financing Cash Flow $1.46M $255,000.00 $1.44M $3.43M $0.00
Net Cash Flow from Continuing Financing Activities $1.46M $255,000.00 $1.44M $3.43M $0.00
Proceeds from Stock Option Exercised $1.46M $255,000.00 $1.44M $3.43M $0.00
Ending Cash Balance $57.57M $62.61M $56.27M $65.26M $65.26M
Net Change in Cash -$5.04M $4.74M -$7.40M $7.67M $6.96M
Beginning Cash Balance $62.61M $56.27M $65.26M $57.59M $58.30M
Free Cash Flow -$38.59M -$39.19M -$52.73M -$118.92M -$19.93M
Net Business Purchase and Sale – – – $0.00 –
Net Issuance Payments Of Debt – – – $0.00 $0.00
Net Common Stock Issuance – – – $0.00 –

Discussion

No comments yet — be the first to weigh in on PACB.

Sign in to join the discussion.

Scroll to Top